《公司業績》德琪醫藥-B(06996.HK)全年虧損收窄至6.01億人幣

You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.

Hong Kong

Open Account

《公司業績》德琪醫藥-B(06996.HK)全年虧損收窄至6.01億人幣

阿思達克 03-28 16:31

德琪醫藥-B(06996.HK)公布截至去年12月底止全年業績，營業額1.6億元人民幣(下同)，按年升456.6%。虧損收窄至6.01億元，上年同期蝕6.56億元；每股虧損0.97元。不派息。撇除以權益結算並以股份為基礎的付款開支帶來的影響，去年經調整虧損收窄至5.5億元，對上財年錄經調整虧損6.13億元。

德琪醫藥-B(06996.HK)

Relevant Stocks

德琪醫藥-B(06996.HK)

Customer Service Hotline︰+852 3018 4526

Email︰cs@usmarthk.com

Address︰26/F, 2606, 308 Des Voeux Road Central, Sheung Wan, Hong Kong

WhatsApp︰+852 5989 2641

Join the Community：

uSmart Securities Limited

is a licensed corporation approved by the Hong Kong SFC (CE number: BJA907), provides securities trading services and is subject to its supervision.

Market News

《公司業績》德琪醫藥-B(06996.HK)全年虧損收窄至6.01億人幣

Services

About Us

Agreement Statement